CAS: 3084-40-0; Diethyl (Hydroxymethyl)Phosphonate

该化合物是有机磷的化合物,其特征是磷分功能组的存在,该物质一般是无色的,淡黄色液体,在有机溶剂中可溶解,含有磷酸衍生物结构,包括两个乙基组和与磷原子相连的氢氧甲基组;该化合物以其在各个领域的应用而著称,包括农业作为潜在的农药或除草剂,以及化学合成作为试剂,其再活动受可参与进一步化学转化的氢氧硫甲基组的存在的影响;此外,该物质与许多有机磷化合物一样,可能展示生物活动,因潜在毒性需要谨慎处理;应查阅安全数据表,以了解处理,储存和处置情况,减轻与接触有关的风险;

结构式图片

相似化合物

31618-90-3 1474-78-8 32806-04-5

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号762-04-9 亚磷酸二乙酯 | CAS号50-00-0 甲醛 | CAS号94-09-7 对氨基苯甲酸乙酯 | CAS号122-52-1 亚磷酸三乙酯 | CAS号75-11-6 二碘甲烷 | CAS号64-17-5 乙醇 | CAS号3167-63-3 氯甲基膦酸二乙酯 | CAS号33512-26-4 邻苯二亚胺甲基磷酸二乙酯 | CAS号38066-16-9 二乙基(苯基硫代甲基)磷酸酯 | CAS号180587-75-1 (R)-9-[2-(二乙基膦酰... | CAS号683-08-9 甲基膦酸二乙酯 | CAS号24600-04-2 1-[chloromethox... | CAS号89268-01-9 diethoxyphospho... | CAS号31618-90-3 对甲苯磺酰氧甲基膦酸二乙酯 | CAS号71885-51-3 [(四氢吡喃-2-基氧代)甲基... | CAS号54553-21-8 2-苯基乙基磷酸二乙酯

合成工艺路线路线简述

  • 合成目标产物 Diethyl (Hydroxymethyl)Phosphonate 主要起始原料 Formaldehyde And Diethyl Phosphite
  • (文献来源)合成步骤主要原料 Formaldehyde 和 Diethyl Phosphite
二乙基亚磷酸氢酯置于三乙胺,Paraformaldehyde体系中,用57.5 G (68%)的收率获得产物羟甲基膦酸二乙酯
参考文献:Phosphonic Acid-Substituted Benzazepinone-N-Acetic Acid Derivatives
标题:Phosphonic Acid-Substituted Benzazepinone-N-Acetic Acid Derivatives
摘要:具有nep抑制活性的化合物,对应于公式i,其中r.Sup.1是氢或形成生物可陌生磷酸酯的基团,R.Sup.2是氢或形成生物可陌生磷酸酯的基团,R.Sup.3是氢或形成生物可陌生羧酸酯的基团,以及公式i的酸的生理上可接受的盐,以及含有这些化合物的药物组合物.

海关参考信息

专利信息


专利号:US-8304409-B2
优先权日:2002-07-03
标 题:Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
发明人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
权利人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI; NICOX SA
摘要:The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

专利号:US-6593347-B2
优先权日:1998-10-30
标题 :Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
发明人:BANDARAGE UPUL K; DONG QING; FANG XINQIN; GARVEY DAVID S; MERCER GREGORY J; RICHARDSON STEWART K; SCHROEDER JOSEPH D; WANG TIANSHENG
权利人:NITROMED INC
摘要:The present invention describes novel nitrosated and/or nitrosylated nonsteroidal antiinflammatory compounds, and novel compositions comprising at least one nitrosated and/or nitrosylated nonsteroidal antiinflammatory compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase. The present invention also provides methods for treating, preventing and/or reducing inflammation, pain, and fever; decreasing or reversing the gastrointestinal, renal and other toxicities resulting from the use of nonsteroidal antiinflammatory drugs; treating and/or preventing gastrointestinal disorders; treating inflammatory disease states and disorders; and treating and/or preventing ophthalmic diseases or disorders.

专利号:US-5852198-A
优先权日:1996-04-03
标题 :Wittig reagents and method for preparing α,β-unsaturated phosphonates
发明人:XU YIBO; FLAVIN MICHAEL T; XU ZE-QI
权利人:MEDICHEM RES INC
摘要:Wittig-type reagents and methods of preparation and use thereof for preparing alpha , beta -unsaturated phosphonate esters from aldehydes and ketones are disclosed. The Wittig-type reagents have the following formulae: I II wherein X represents triflate, halide, BF4, SbF6, or ClO4; R1 represents alkyl, aryl or arylalkyl; and R2 represents alkyl, aryl or arylalkyl, provided that R1 and R2 not represent phenyl at the same time. The Wittig reagent diethyl phosphono-methylidenetriphenylphosphorane (1b) has been successfully synthesized for the first time via its phosphonium triflate salt (4a), by treating diethyl phosphonomethyltriflate with triphenylphosphine according to the disclosed method. The procedure has been applied to the synthesis of other new Wittig-type reagents such as phosphoranes and phosphonium salts. The new Wittig reagents thus synthesized were treated with various aldehydes and an activated ketone, affording the corresponding alpha , beta -unsaturated phosphonates, saturated phosphonates or phosphoric acids. Triphenylphosphorane 1b and triphenylphosphonium 4a led to both cis and trans isomers with the latter being predominant, while trans isomers were almost exclusively formed when tributyl reagents (1c and 4d) were used.

专利号:US-6320040-B1
优先权日:1990-07-27
标题:4-desmethyl nucleoside analogs and oligomers thereof
发明人:COOK PHILLIP DAN; TENG KELLY
权利人:ISIS PHARMACEUTICALS INC
摘要:Tetrahydrofuranyl compounds are provided that are functionalized to include pendant conjugate groups, and which are useful in diagnosis assays and as research reagents. Novel intermediates for the synthesis of the compounds are also provided.

专利号:US-4536355-A
优先权日:1982-10-08
标题 :Phenoxyphenylaminoalkylphosphinates useful in weed control
发明人:LEE SHY-FUH; HENRICK CLIVE A
权利人:ZOECON CORP
摘要:Novel phenoxyphenoxyalkyl-, phenoxyphenylthioalkyl- or phenoxyphenylsulfonylalkyl-substituted phosphinates and phosphonates, related compounds, synthesis thereof, intermediates therefor, and the use of said novel compounds for the control of weeds.

专利号:US-4456464-A
优先权日:1982-05-19
标题 :Phenoxy- and pyridyloxy-phenoxyalkyl phosphinates and related sulfur compounds for weed control
发明人:LEE SHY-FUH; HENRICK CLIVE A
权利人:ZOECON CORP
摘要:Novel phenoxyphenoxyalkyl-, phenoxyphenylthioalkyl- or phenoxyphenylsulfonylalkyl-substituted phosphinates and phosphonates, related compounds, synthesis thereof, intermediates therefor, and the use of said novel compounds for the control of weeds.
黄石市福尔泰化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.fuertaichem.com
电话: 0714-6392341👤
📞黄石市福尔泰化工有限公司 ⚠️参考联系方式

销售电话:0714-6392341
邮箱:sales@fuertaichem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东丰源化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.sdfypharm.com
企业联系电话:13310669559👤
📞山东丰源化工有限公司 ⚠️参考联系方式
联系人:崔总
电话:13310669559
手机:13310669559
传真:0532-80922987
邮箱:13310669559@163.com
通信地址: 青岛市城阳区三里庄环保产业园
邮编: 460000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:青岛市城阳区三里庄环保产业园
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海金洹化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jinhchem.com
企业联系电话:021-52210535👤
📞上海金洹化工有限公司 ⚠️参考联系方式
联系人:陈经理
电话:021-52210535
手机:13162045318
传真:021-67285091
邮箱:sales@jinhchem.com
通信地址: 上海市闵行区龙吴路5688弄89号202室
邮编: 200071
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市闵行区龙吴路5688弄89号202室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
摘要:Leroy, B., Science of Synthesis, (2007) 29, 290.
摘要:Drabowicz, J.; Kiełbasiński, P.; Łyżwa, P.; Mikołajczyk, M.; Zając, A., Science of Synthesis, (2009) 42, 688.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知